Pharmacy(BK4007),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BK4007 Pharmacy

Market Closed 05-01 16:00:00 EDT

864.37

+5.28

+0.61%

High873.04	Low859.14	Vol448.88M
Open859.14	D1 Closing859.09	Amplitude1.62%
Mkt Cap0.00	Tradable Cap0.00	Total Shares0.00
T/O15.19B	T/O Rate--	Tradable Shares0.00
P/B5.04648	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"BK4007","market":"US","secType":"PLATE","nameCN":"Pharmacy","latestPrice":864.3691,"timestamp":1777665599999,"preClose":859.08875,"halted":0,"volume":448883131,"delay":0,"changeRate":0.006146,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":5.280334,"latestTime":"05-01 16:00:00 EDT","open":859.1447,"high":873.03613,"low":859.1447,"amount":15193817108.289244,"amplitude":0.01617,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1777881600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":5.04648,"peRate":25.832765,"turnoverRate":0.010196,"increases":106,"decrements":75,"flats":7,"marketCap":3402657668937.625,"floatMarketCap":3250752643899.25},"requestUrl":"/m/hq/s/BK4007/tweets","defaultTab":"tweets","newsList":[{"id":"2632289629","title":"Eloxx Pharmaceuticals initial beneficial ownership statement names Coastlands Capital LP as 10% owner","url":"https://stock-news.laohu8.com/highlight/detail?id=2632289629","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632289629?lang=en_us&edition=fundamental","pubTime":"2026-05-02 09:46","pubTimestamp":1777686361,"startTime":"0","endTime":"0","summary":"Coastlands Capital LP filed Form 3 reporting beneficial ownership in Eloxx Pharmaceuticals, marking 10% owner status as of April 27, 2026.Filing shows indirect ownership of 1,250,000 shares of common stock.It also reports 29,362,243 pre-funded warrants exercisable into common stock at USD 0.01 per share.Pre-funded warrants have no expiration date, with exercise subject to a 4.99% beneficial ownership cap.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Eloxx Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 01, 2026, and is solely responsible for the information cont","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260502:nNDL4BsHcT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELOX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632626194","title":"Indivior Earnings Call Highlights SUBLOCADE-Fueled Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=2632626194","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632626194?lang=en_us&edition=fundamental","pubTime":"2026-05-02 08:09","pubTimestamp":1777680579,"startTime":"0","endTime":"0","summary":"Indivior plc (($INDV)) has held its Q1 earnings call. Read on for the main highlights of the call. Indivior’s latest earnings call struck an upbeat...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/indivior-earnings-call-highlights-sublocade-fueled-momentum?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/indivior-earnings-call-highlights-sublocade-fueled-momentum?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","INDV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632626579","title":"Eterna Therapeutics trading halted, news pending","url":"https://stock-news.laohu8.com/highlight/detail?id=2632626579","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632626579?lang=en_us&edition=fundamental","pubTime":"2026-05-02 07:51","pubTimestamp":1777679502,"startTime":"0","endTime":"0","summary":"19:50 EDT Eterna Therapeutics trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-moving breaking fi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/eterna-therapeutics-trading-halted-news-pending-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/eterna-therapeutics-trading-halted-news-pending-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4539","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632862578","title":"Pharvaris Chief Early Development Anne Lesage disposes of shares worth $1.32 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2632862578","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632862578?lang=en_us&edition=fundamental","pubTime":"2026-05-02 07:31","pubTimestamp":1777678288,"startTime":"0","endTime":"0","summary":"Pharvaris Chief Early Development Anne Lesage sold 25,400 shares April 29-30.Lesage also exercised options for 25,400 shares at USD 2.59-8.05.Directly held common stock ended unchanged at 56,450 shares.GrayMatters Consulting BV, controlled by Lesage, cut its stake to 133,969 shares from 156,869.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pharvaris NV published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 01, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260501:nNDL7F7NMS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Pharvaris Chief Early Development Anne Lesage disposes of shares worth $1.32 million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PHVS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632623017","title":"Immunovant director Robert Graham Susman sells 2,502 shares for $67,988.34","url":"https://stock-news.laohu8.com/highlight/detail?id=2632623017","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632623017?lang=en_us&edition=fundamental","pubTime":"2026-05-02 06:40","pubTimestamp":1777675258,"startTime":"0","endTime":"0","summary":"Immunovant director Robert Graham Susman sold 2,502 shares of common stock on May 1, 2026.Sale priced at weighted average USD 27.17 per share.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immunovant Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 01, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260501:nNDL5l0JhS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMVT","BK4007","ROIV","BK4588","BK4139","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632623599","title":"Veradermics Boosts Capital Through Public Offering and Warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2632623599","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632623599?lang=en_us&edition=fundamental","pubTime":"2026-05-02 05:52","pubTimestamp":1777672358,"startTime":"0","endTime":"0","summary":"Veradermics, Incorporated ( ($MANE) ) has shared an announcement. On May 1, 2026, Veradermics, Incorporated closed an underwritten public offering ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/veradermics-boosts-capital-through-public-offering-and-warrants?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/veradermics-boosts-capital-through-public-offering-and-warrants?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","MANE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632623851","title":"Xeris Biopharma CLO Beth Hecht disposes 16,667 shares for $103,804.31","url":"https://stock-news.laohu8.com/highlight/detail?id=2632623851","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632623851?lang=en_us&edition=fundamental","pubTime":"2026-05-02 05:51","pubTimestamp":1777672288,"startTime":"0","endTime":"0","summary":"Xeris Biopharma Chief Legal Officer, Corporate Secretary Beth Hecht reported sale of 16,667 common shares on May 1, 2026.Sale priced at weighted average USD 6.23 per share.Hecht beneficial ownership fell to 1,193,173 shares following transaction.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xeris Biopharma Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 01, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260501:nNDL70DLFr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Xeris Biopharma CLO Beth Hecht disposes 16,667 shares for $103,804.31","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XERS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632623909","title":"Is It Time To Reconsider Aurora Innovation (AUR) After Its Recent Share Price Surge?","url":"https://stock-news.laohu8.com/highlight/detail?id=2632623909","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632623909?lang=en_us&edition=fundamental","pubTime":"2026-05-02 05:47","pubTimestamp":1777672064,"startTime":"0","endTime":"0","summary":"Investors may be wondering whether Aurora Innovation's share price reflects its true worth, or if the market is mispricing the story right now.\nThe stock recently closed at US$6.13, with returns of 24.8% over 7 days, 46.7% over 30 days, 58.4% year to date, and a 24.7% decline over the past year, alongside a very large gain over 3 years.\nRecent coverage has focused on how autonomous driving and AI related names are being reassessed by investors, as attention shifts to companies tied to real...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/8041000-choice2-main-header/1585186556238","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/8041000-choice2-main-header/1585186556238"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/software/nasdaq-aur/aurora-innovation/news/is-it-time-to-reconsider-aurora-innovation-aur-after-its-rec","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/software/nasdaq-aur/aurora-innovation/news/is-it-time-to-reconsider-aurora-innovation-aur-after-its-rec","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4007","BK4137","DCF","ACB","MSOS","AUR.AU","BK4023","BK4557","BK7095","AUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632623940","title":"Is Corcept Therapeutics (CORT) Pricing Make Sense After Recent Volatility In The Share Price","url":"https://stock-news.laohu8.com/highlight/detail?id=2632623940","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632623940?lang=en_us&edition=fundamental","pubTime":"2026-05-02 05:47","pubTimestamp":1777672023,"startTime":"0","endTime":"0","summary":"If you are wondering whether Corcept Therapeutics at around US$51.42 is attractively priced or already stretched, starting with a clear view of valuation can help frame your next move.\nThe stock has seen sharp swings recently, with returns of 11.6% over 7 days, 22.5% over 30 days, 34.6% year to date, but a 29.3% decline over the past year and gains of 113.6% over 3 years and 143.7% over 5 years.\nRecent coverage has focused on how this price history shapes expectations for Corcept...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-cort/corcept-therapeutics/news/is-corcept-therapeutics-cort-pricing-make-sense-after-recent","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-cort/corcept-therapeutics/news/is-corcept-therapeutics-cort-pricing-make-sense-after-recent","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4007","BK4211","LU1559883803.SGD","FCF","LU0566484027.USD","DCF","BK4532","CORT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632628757","title":"Contineum CSO Daniel S. Lorrain sells USD 54,741 in common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2632628757","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632628757?lang=en_us&edition=fundamental","pubTime":"2026-05-02 05:43","pubTimestamp":1777671806,"startTime":"0","endTime":"0","summary":"Contineum Therapeutics Chief Scientific Officer Daniel S. Lorrain sold 4,170 shares of Class A common stock on May 1, 2026.Sales were reported at weighted average prices of $13.06 and $13.84.Lorrain reported 143,542 shares owned directly following transactions.Filing also showed 6,842 shares held indirectly by spouse.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Contineum Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 01, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260501:nNDLbLqCyc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Contineum CSO Daniel S. Lorrain sells USD 54,741 in common shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CTNM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632287396","title":"NYSE Most Active Issues","url":"https://stock-news.laohu8.com/highlight/detail?id=2632287396","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632287396?lang=en_us&edition=fundamental","pubTime":"2026-05-02 05:41","pubTimestamp":1777671660,"startTime":"0","endTime":"0","summary":"Blue Owl Capital             OWL    53,091,628      9.98     0.23      2.36. iSh 0-3M Treasury Bd        SGOV    33,307,421    100.41     0.04      0.04. Norwegian Cruise Line       NCLH    31,347,607     18.81     0.63      3.47. BitMine Immersion Techs     BMNR    29,508,874     21.88     0.48      2.24. Novo Nordisk ADR             NVO    26,206,587     43.88     1.66      3.93","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0225284248.USD","NYSE","PATX","IE0002270589.USD","NVO","AMC","IE000M9KFDE8.USD","BK4561","LU0321505439.SGD","LU0868494617.USD","NVOH","BK4533","SG9999001176.SGD","BK4585","LU0122379950.USD","IE00B19Z3B42.SGD","PATH","NVOX","LU0985481810.HKD","LU1894683264.USD","LU0058720904.USD","LU1057294990.SGD","SGXZ57979304.SGD","IE00BZ1G4Q59.USD","BK4599","LU1894683348.USD","SG9999011175.SGD","BK4532","BK4534","SG9999001176.USD","JOBX","PFE","BK4588","BK4008","IE00BKVL7J92.USD","IE00BBT3K403.USD","LU0456855351.SGD","LU0234572021.USD","BK4007","LU1861558580.USD","JOBY","LU1093756325.SGD","LU0289739699.SGD","BK4539","LU0306807586.USD","LU1066051498.USD","LU0321505868.SGD","BK4568","SG9999013999.USD","BK4603"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632628909","title":"Novavax Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2632628909","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632628909?lang=en_us&edition=fundamental","pubTime":"2026-05-02 05:29","pubTimestamp":1777670940,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Novavax Inc.  rose 1.45% to $8.04 Friday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index  rising 0.89% to 25,114.44 and the Dow Jones Industrial Average  falling 0.31% to 49,499.27.Novavax Inc. closed 32.83% short of its 52-week high of $11.97, which the company reached on February 26th.The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Johnson & Johnson  fell 1.16% to $227.19, Pfizer Inc.  fell 1.39% to $26.33, and Merck & Co. Inc.  rose 2.73% to $112.16.Trading volume  remained 1.1 million below its 50-day average volume of 4.2 M.Data source: Dow Jones Market Data, FactSet. Data compiled May 1, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE000F7OJYX1.SGD","LU2471134952.CNY","LU1162221912.USD","IE00BLSP4239.USD","LU1032466523.USD","LU1430594728.SGD","BK4504","LU1935042991.SGD","LU2602419157.SGD","LU1778281490.HKD","LU1037948541.HKD","LU0942090050.USD","LU1037948897.HKD","LU1035773651.USD","LU1917777945.USD","LU0234572021.USD","LU1196500208.SGD","LU0306807586.USD","LU0266013472.USD","LU0238689110.USD","LU0320765646.SGD","LU0820562030.AUD","SGXZ57979304.SGD","LU1228905037.USD","LU0106261372.USD","LU0345770993.USD","LU0203347892.USD","LU0820561909.HKD","LU0208291251.USD","LU1066051225.USD","LU2468319806.SGD","LU2125154935.USD","LU0265550946.USD","LU1894683348.USD","IE0002270589.USD","IE00BN8TJ469.HKD","LU1732799900.SGD","LU1934455194.USD","LU2750360997.AUD","IE000MB6IJN5.SGD","LU1093756168.USD","SG9999002232.USD","LU2129689431.USD","LU0868494617.USD","SG9999015341.SGD","LU0130102774.USD","LU1934455277.USD","LU0070302665.USD","LU1989772840.SGD","LU0345769631.USD","LU0965509010.AUD","IE00BZ1G4Q59.USD","LU0225284248.USD","LU0477156953.USD","LU2112291526.USD","LU2129689605.HKD","IE00BLSP4452.SGD","LU1929549753.HKD","LU2106854487.HKD","LU2505996509.AUD","LU2360032135.SGD","LU0114720955.EUR","LU0320765489.SGD","LU0985320562.USD","IE00B3PB1722.GBP","BK4534","IE00B19Z3581.USD","LU2756315664.SGD","LU0225771236.USD","IE00BFTCPJ56.SGD","LU1699723380.USD","SG9999001176.USD","LU0980610538.SGD","LU2023250330.USD","IE00B1BXHZ80.USD","LU1121112475.USD","IE00BGHQF631.EUR","BK4588","LU0882574055.USD","LU2461242641.AUD","LU0795875086.SGD","NVAX","SG9999001176.SGD","BK4139","IE0000B7K699.USD","LU1267930813.SGD","LU1291159041.SGD","LU0456855351.SGD","IE00BJT1NW94.SGD","IE0034235303.USD","LU0648001328.SGD","LU2129689514.USD","LU1116320901.HKD","LU1551013425.SGD","LU0211331839.USD","LU2023250843.SGD","LU0006306889.USD","SG9999015358.SGD","IE00B42XCP33.USD","IE00B3T34201.USD","LU2505996681.GBP","SG9999014575.USD","IE00B2B36J28.USD","BK4547","LU0889566641.SGD","LU1280957306.USD","LU1074936037.SGD","LU1883839398.USD","LU2430703251.USD","SG9999002224.SGD","LU2361045086.USD","LU1244550494.USD","SG9999014542.SGD","LU2487616109.SGD","LU0426417589.USD","IE00BDGV0183.EUR","LU0965508806.USD","LU0053666078.USD","LU1032955483.USD","LU1043141123.HKD","LU1244550577.SGD","IE0002141913.USD","LU2430703178.SGD","LU2471134796.USD","LU0203345920.USD","LU0964807845.USD","BK4007","LU0210536198.USD","LU2347655156.SGD","LU2491049909.HKD","LU0289739699.SGD","LU1732800096.USD","LU2125154778.USD","LU1066053197.SGD","LU2324357040.USD","LU2491050154.USD","BK4516","LU1043141396.HKD","LU1629891620.HKD","LU2430703095.HKD","IE00BVYPNW00.USD","LU1023059063.AUD","LU1061106388.HKD","IE0001KFT4U8.USD","LU1066051811.HKD","LU2361044949.HKD","IE000WAW04H5.SGD","IE0009355771.USD","LU0345770308.USD","LU1934455863.HKD","LU0689626769.HKD","LU1989771016.USD","IE000BZT7R73.USD","LU0689472784.USD","IE000SO60NU8.SGD","SG9999014567.USD","IE00BSNM7G36.USD","LU1506573853.SGD","LU1941712348.USD","LU2471134879.HKD","LU0868494708.USD","IE00BVYPNV92.GBP","LU0124676726.USD","LU2896262040.SGD","LU1057294990.SGD","LU1069347547.HKD","IE00BJJMRZ35.SGD","LU1914381329.SGD","LU1093756325.SGD","IE00BBT3K403.USD","LU0345769128.USD","LU1244550221.USD","LU2491050071.SGD","SG9999014559.SGD","IE00B7SZLL34.SGD","LU1261432733.SGD","BK4559","LU1894683264.USD","LU2756315318.SGD","IE00B19Z3B42.SGD","LU0234570918.USD","LU0787776722.HKD","BK4599","LU0058720904.USD","LU2357627491.SGD","LU0070217475.USD","IE00B4R5TH58.HKD","LU0432979614.USD","LU2592432038.USD","LU0426412945.USD","SG9999011175.SGD","LU0792757196.USD","LU0098860793.USD","LU1941712264.USD","LU1145028129.USD","LU2361044865.SGD","LU1674673428.USD","LU1585245621.USD","LU0965509101.SGD","LU0985481810.HKD","LU0122379950.USD","LU0683600562.USD","LU2133065610.SGD","LU1066051498.USD","LU1221951046.USD","LU1221951129.SGD","IE000M9KFDE8.USD","LU0265550359.USD","LU1718418525.SGD","LU1551013342.USD","LU2213496289.HKD","LU1116320737.USD","LU0466842654.USD","LU1496350502.SGD","LU1674673691.USD","IE00BFXG1179.USD","LU0210528500.USD","BK4550","LU0820561818.USD","LU0965509283.SGD","LU0861579265.USD","LU0943347566.SGD","LU0859254822.USD","LU1974910355.USD","LU2471134523.USD","LU1228905540.USD","LU2750360641.GBP","BK4592","LU1201861249.SGD","LU0640476718.USD","LU2089984988.USD","LU0170899867.USD","LU0321505439.SGD","BK4533","LU1983299246.USD","SG9999013999.USD","LU0130517989.USD","IE00BKVL7J92.USD","BK4581","LU0321505868.SGD","LU0795875169.SGD","LU2023250504.SGD","BK4568","LU0306806265.USD","BK4532","LU0994945656.USD","LU1059921491.USD","LU1571399168.USD","LU0545562505.USD","LU1989772923.USD","LU0912757837.SGD","SG9999003800.SGD","BK4585","SG9999001440.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632628917","title":"Inovio Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2632628917","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632628917?lang=en_us&edition=fundamental","pubTime":"2026-05-02 05:26","pubTimestamp":1777670760,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Inovio Pharmaceuticals Inc.  shed 1.79% to $1.10 Friday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index  rising 0.89% to 25,114.44 and the Dow Jones Industrial Average  falling 0.31% to 49,499.27.Inovio Pharmaceuticals Inc. closed 63.07% below its 52-week high of $2.98, which the company achieved on September 9th.The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson  fell 1.16% to $227.19, Statera Biopharma Inc.  remained unchanged, and Pfizer Inc.  fell 1.39% to $26.33.Trading volume  remained 650,054 below its 50-day average volume of 1.8 M.Data source: Dow Jones Market Data, FactSet. Data compiled May 1, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journa","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999001176.SGD","LU0426412945.USD","IE0001KFT4U8.USD","LU1121112475.USD","LU2602419157.SGD","LU1057294990.SGD","LU0964807845.USD","IE00BSNM7G36.USD","LU1228905540.USD","LU0985320562.USD","IE000F7OJYX1.SGD","LU1935042991.SGD","LU0053666078.USD","LU2129689514.USD","LU0306806265.USD","IE000BZT7R73.USD","LU1506573853.SGD","IE00BFTCPJ56.SGD","IE0009355771.USD","BK4588","IE00BVYPNV92.GBP","BK4550","LU0640476718.USD","SG9999001176.USD","IE00BJT1NW94.SGD","LU2129689605.HKD","LU2430703178.SGD","LU0345770308.USD","SG9999002224.SGD","BK4532","LU1914381329.SGD","LU0466842654.USD","LU1066051811.HKD","LU1718418525.SGD","LU0426417589.USD","LU2471134879.HKD","LU2896262040.SGD","LU0114720955.EUR","LU0170899867.USD","LU0058720904.USD","LU2023250330.USD","BK4568","LU1929549753.HKD","LU2129689431.USD","LU2112291526.USD","IE00B7SZLL34.SGD","LU2089984988.USD","IE000SO60NU8.SGD","LU1032955483.USD","IE00BFXG1179.USD","LU1585245621.USD","IE00B3PB1722.GBP","LU1145028129.USD","SG9999002232.USD","LU0320765646.SGD","BK4592","LU1267930813.SGD","LU0994945656.USD","LU0795875169.SGD","BK4583","LU0289739699.SGD","LU1043141396.HKD","IE0034235303.USD","LU1061106388.HKD","LU2592432038.USD","LU2430703251.USD","SG9999001440.SGD","LU0225771236.USD","LU0210528500.USD","LU2430703095.HKD","LU1074936037.SGD","LU2213496289.HKD","BK4534","LU0124676726.USD","LU2471134523.USD","IE00BN8TJ469.HKD","BK4581","LU0689626769.HKD","IE00B2B36J28.USD","LU1629891620.HKD","IE00BBT3K403.USD","LU0820561818.USD","LU1551013342.USD","LU0912757837.SGD","LU0234570918.USD","SG9999011175.SGD","LU0070217475.USD","LU1983299246.USD","IE00B19Z3581.USD","LU1280957306.USD","IE00B4R5TH58.HKD","LU2468319806.SGD","LU0234572021.USD","LU0792757196.USD","LU1551013425.SGD","LU2505996509.AUD","LU1894683264.USD","IE00B3T34201.USD","BK4139","LU1430594728.SGD","BK4533","IE000MB6IJN5.SGD","IE00BKVL7J92.USD","LU0306807586.USD","IE00B42XCP33.USD","IE0002270589.USD","LU0689472784.USD","LU1496350502.SGD","LU1244550577.SGD","BK4504","IE0000B7K699.USD","LU0345769128.USD","LU1023059063.AUD","LU0683600562.USD","LU1043141123.HKD","IE000M9KFDE8.USD","IE00BGHQF631.EUR","LU0545562505.USD","LU2133065610.SGD","LU0868494617.USD","BK4599","LU1066051225.USD","LU0432979614.USD","LU0321505868.SGD","LU1244550221.USD","LU2347655156.SGD","LU0820561909.HKD","IE00B19Z3B42.SGD","LU1674673428.USD","LU1732799900.SGD","IE00BZ1G4Q59.USD","INO","LU2505996681.GBP","IE00BLSP4239.USD","LU1221951046.USD","LU1162221912.USD","SGXZ57979304.SGD","LU1883839398.USD","LU1228905037.USD","LU2756315664.SGD","LU2487616109.SGD","BK4585","LU0889566641.SGD","LU1221951129.SGD","LU1732800096.USD","IE00B1BXHZ80.USD","LU0203345920.USD","LU0985481810.HKD","LU0882574055.USD","IE000WAW04H5.SGD","LU0203347892.USD","IE00BLSP4452.SGD","LU2471134796.USD","LU1244550494.USD","LU1196500208.SGD","LU0321505439.SGD","LU1066053197.SGD","LU1032466523.USD","LU1261432733.SGD","LU0122379950.USD","LU1778281490.HKD","BK4559","LU0456855351.SGD","IE00BDGV0183.EUR","LU0943347566.SGD","LU0098860793.USD","LU1066051498.USD","IE00BJJMRZ35.SGD","LU2471134952.CNY","SG9999013999.USD","BK4007","LU0820562030.AUD","LU2750360997.AUD","LU1894683348.USD","IE0002141913.USD","LU0210536198.USD","LU0795875086.SGD","LU0345769631.USD","LU0225284248.USD","SG9999003800.SGD","LU1674673691.USD","LU0345770993.USD","LU1059921491.USD","LU0787776722.HKD","LU2756315318.SGD","IE00BVYPNW00.USD","LU2750360641.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632628943","title":"Catalyst Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2632628943","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632628943?lang=en_us&edition=fundamental","pubTime":"2026-05-02 05:22","pubTimestamp":1777670520,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Catalyst Pharmaceuticals Inc.  advanced 2.17% to $28.74 Friday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index  rising 0.89% to 25,114.44 and the Dow Jones Industrial Average  falling 0.31% to 49,499.27.The stock's rise snapped a two-day losing streak.Catalyst Pharmaceuticals Inc. closed 11.73% below its 52-week high of $32.56, which the company reached on April 27th.The stock outperformed some of its competitors Friday, as Johnson & Johnson  fell 1.16% to $227.19, Pfizer Inc.  fell 1.39% to $26.33, and Abbott Laboratories  fell 1.46% to $89.46.Trading volume  remained 89,576 below its 50-day average volume of 1.5 M.Data source: Dow Jones Market Data, FactSet. Data compiled May 1, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Ne","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0868494617.USD","LU1691799644.USD","LU1989763690.USD","IE00B19Z6F94.USD","LU2129689605.HKD","BK4007","IE00B7SZLL34.SGD","LU1059921491.USD","LU0426412945.USD","LU1145028129.USD","LU1430594728.SGD","LU2750360641.GBP","LU0689626769.HKD","BK4139","LU1261432733.SGD","IE00BZ1G4Q59.USD","LU2756315664.SGD","LU0882574055.USD","BK4566","LU1221951129.SGD","SG9999001176.USD","LU1061106388.HKD","SG9999002224.SGD","LU0912757837.SGD","SG9999013999.USD","LU0321505439.SGD","IE000MB6IJN5.SGD","IE00BJJMRZ35.SGD","LU2133065610.SGD","LU1162221912.USD","LU2487616109.SGD","LU2505996681.GBP","IE00BN8TJ469.HKD","LU0070217475.USD","SG9999011175.SGD","LU1732799900.SGD","LU1585245621.USD","LU0985481810.HKD","IE00BVYPNV92.GBP","LU1496350502.SGD","LU1983299246.USD","IE0002270589.USD","LU0466842654.USD","LU2112291526.USD","IE00BLSP4452.SGD","LU0994945656.USD","LU1674673691.USD","LU0545562505.USD","IE000SO60NU8.SGD","IE00BJT1NW94.SGD","LU1721429741.USD","IE0002141913.USD","SG9999001176.SGD","LU0985320562.USD","LU1244550221.USD","IE00BLSP4239.USD","LU0058720904.USD","LU0306807586.USD","LU1043141123.HKD","IE00BVYPNW00.USD","LU1244550577.SGD","LU0943347566.SGD","IE000WAW04H5.SGD","LU0170899867.USD","LU1718418525.SGD","LU2211815571.USD","IE0001KFT4U8.USD","LU1506573853.SGD","LU1989763427.SGD","LU2505996509.AUD","LU0426417589.USD","LU0787776722.HKD","LU0321505868.SGD","LU0889566641.SGD","SGXZ57979304.SGD","IE00B19Z3581.USD","LU1551013342.USD","LU0320765646.SGD","LU0203345920.USD","LU2602419157.SGD","LU1244550494.USD","LU0234570918.USD","LU1721429402.USD","LU2430703095.HKD","LU1883839398.USD","LU0306806265.USD","LU1732800096.USD","LU2471134879.HKD","LU0122379950.USD","LU2430703251.USD","LU0124676726.USD","LU2237957902.USD","LU1221951046.USD","IE000F7OJYX1.SGD","LU1057294990.SGD","LU0689472784.USD","BK4534","LU1778281490.HKD","SG9999004303.SGD","LU1894683264.USD","BK4532","LU0432979614.USD","IE00B42XCP33.USD","LU1032466523.USD","BK4082","IE00B3T34201.USD","LU0964807845.USD","LU0456855351.SGD","IE000BZT7R73.USD","LU2237957811.SGD","LU0345769128.USD","LU0210536198.USD","LU1629891620.HKD","LU0203347892.USD","LU0225284248.USD","BK4585","LU1121112475.USD","LU1894683348.USD","LU0820562030.AUD","LU1914381329.SGD","LU2471134952.CNY","BK4533","IE00B2B36J28.USD","LU0098860793.USD","LU2592432038.USD","LU1674673428.USD","LU1196500208.SGD","LU2213496289.HKD","BK4592","IE00BGHQF631.EUR","LU1066053197.SGD","IE0000B7K699.USD","LU2430703178.SGD","LU0345770308.USD","LU2756315318.SGD","IE0034390439.USD","LU2129689514.USD","IE00B19Z3B42.SGD","LU1066051498.USD","LU2129689431.USD","LU2347655156.SGD","IE00B4R5TH58.HKD","LU2468319806.SGD","SGXZ23171101.USD","IE00BBT3K403.USD","LU1066051225.USD","LU0795875169.SGD","SGXZ41872573.SGD","LU0114720955.EUR","CPRX","LU1929549753.HKD","LU1043141396.HKD","IE00BKVL7J92.USD","LU0640476718.USD","BK4504","LU0225771236.USD","BK4550","LU0289739699.SGD","LU2750360997.AUD","LU1023059063.AUD","LU1032955483.USD","IE00BSNM7G36.USD","LU0266013472.USD","BK4599","IE00B3PB1722.GBP","LU2324357040.USD","LU0053666078.USD","LU0345769631.USD","LU1074936037.SGD","IE0034235303.USD","IE000M9KFDE8.USD","LU1267930813.SGD","BK4581","LU1066051811.HKD","LU1551013425.SGD","LU2896262040.SGD","IE00BFXG1179.USD","LU0792757196.USD","SG9999002232.USD","LU2471134796.USD","LU0345770993.USD","LU0234572021.USD","IE00BFTCPJ56.SGD","LU2023250330.USD","LU2471134523.USD","BK4588","LU0210528500.USD","LU1228905540.USD","LU0820561909.HKD","LU2089984988.USD","LU1228905037.USD","IE00BDGV0183.EUR","LU1280957306.USD","IE0009355771.USD","LU0683600562.USD","SG9999001440.SGD","BK4559","LU0795875086.SGD","LU1935042991.SGD","LU0820561818.USD","SG9999003800.SGD","IE00B1BXHZ80.USD","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632640240","title":"Biogen Inc. Stock Underperforms Friday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2632640240","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632640240?lang=en_us&edition=fundamental","pubTime":"2026-05-02 05:00","pubTimestamp":1777669200,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Biogen Inc.  shed 1.17% to $187.06 Friday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index  rising 0.29% to 7,230.12 and the Dow Jones Industrial Average  falling 0.31% to 49,499.27.This was the stock's second consecutive day of losses.Biogen Inc. closed 7.58% short of its 52-week high of $202.41, which the company reached on February 6th.The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Johnson & Johnson  fell 1.16% to $227.19, Pfizer Inc.  fell 1.39% to $26.33, and AbbVie Inc.  fell 2.23% to $206.60.Trading volume  remained 446,694 below its 50-day average volume of 1.1 M.Data source: Dow Jones Market Data, FactSet. Data compiled May 1, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","LU2750360997.AUD","LU0738911758.USD","IE00BJJMRZ35.SGD","LU1883839398.USD","LU2129689431.USD","LU2213496289.HKD","LU1043141396.HKD","LU0058720904.USD","LU1228905540.USD","LU0795875169.SGD","SG9999015945.SGD","LU0965509010.AUD","LU0211327993.USD","LU0345770993.USD","LU0859254822.USD","IE00BFXG1179.USD","LU0466842654.USD","IE000M9KFDE8.USD","IE000SO60NU8.SGD","LU1066051498.USD","IE00BN8TJ469.HKD","LU1032466523.USD","LU0053666078.USD","LU0098860793.USD","BK4599","LU0345769128.USD","LU1221951046.USD","LU0289739343.SGD","BK4592","LU1894683264.USD","LU1037948541.HKD","LU1037948897.HKD","LU1496350502.SGD","SG9999001176.USD","LU0306807586.USD","IE00B3T34201.USD","LU0289739699.SGD","LU1674673691.USD","LU2089284900.SGD","LU1244550494.USD","IE00B19Z9P08.USD","LU1989771016.USD","LU2430703251.USD","IE0034235303.USD","LU0321505868.SGD","LU2468319806.SGD","LU2129689514.USD","SG9999001440.SGD","SG9999001176.SGD","IE00BLSP4239.USD","LU2237443978.SGD","IE00BVYPNV92.GBP","IE00B3PB1722.GBP","LU0345770308.USD","LU2237443622.USD","LU1839511570.USD","LU1066051225.USD","IE00B1BXHZ80.USD","LU1914381329.SGD","LU2087621335.USD","BK4585","SG9999011175.SGD","LU0211328371.USD","LU0861579265.USD","IE00B19Z9Z06.USD","LU0057025933.USD","LU1267930490.SGD","LU2756315664.SGD","LU1145028129.USD","LU0640476718.USD","IE00BJT1NW94.SGD","LU0965509101.SGD","LU0320765992.SGD","IE00BLSP4452.SGD","LU0545039389.USD","LU1496350171.SGD","LU1267930573.SGD","LU2357627491.SGD","LU0114720955.EUR","LU2471134879.HKD","LU1093756168.USD","IE00BGHQF631.EUR","LU0889566641.SGD","LU1894683348.USD","LU0964807845.USD","BK4504","LU1989772923.USD","LU2602419157.SGD","BK4139","LU1228905037.USD","LU2237443895.HKD","IE00BKVL7J92.USD","SGXZ57979304.SGD","LU2896262040.SGD","LU2592432038.USD","IE00B19Z3581.USD","LU1032955483.USD","LU1934455863.HKD","LU2129689605.HKD","LU0210536198.USD","LU0225284248.USD","IE00BFTCPJ56.SGD","LU0158827948.USD","LU1732800096.USD","LU0985481810.HKD","LU1244550577.SGD","LU1280957306.USD","LU2089984988.USD","LU0256863811.USD","IE0001KFT4U8.USD","LU1674673428.USD","LU2430703178.SGD","LU0345769631.USD","LU0122379950.USD","LU0708994859.HKD","LU2505996681.GBP","IE000MB6IJN5.SGD","BK4534","LU1059921491.USD","LU1778281490.HKD","BK4568","LU0787776722.HKD","LU1043141123.HKD","LU1003077747.HKD","LU0417517546.SGD","LU0553294199.USD","LU1261432733.SGD","LU2430703095.HKD","IE00BBT3K403.USD","LU0289961442.SGD","LU0994945656.USD","LU2471134523.USD","LU1989772840.SGD","IE00B19Z3B42.SGD","LU1221951129.SGD","LU0310800379.SGD","LU0256863902.USD","LU0472753341.HKD","LU0170899867.USD","LU2133065610.SGD","LU0321505439.SGD","LU0198837287.USD","BK4007","LU2237443382.USD","IE0004445239.USD","IE00B894F039.SGD","LU0234572021.USD","LU2750360641.GBP","LU1061106388.HKD","LU2237443549.SGD","LU1585245621.USD","IE00B2B36J28.USD","LU1629891620.HKD","LU0949170772.SGD","LU0545562505.USD","LU2023251221.USD","LU2471134952.CNY","LU0868494617.USD","LU1244550221.USD","IE000WAW04H5.SGD","LU0912757837.SGD","LU1162221912.USD","LU1121112475.USD","LU0820561818.USD","IE0009355771.USD","LU0985320562.USD","LU1935042991.SGD","LU0823416689.USD","LU0310799852.SGD","IE000BZT7R73.USD","LU0868494708.USD","LU0426412945.USD","LU0456855351.SGD","LU2089283258.USD","IE00BZ1G4Q59.USD","LU0306806265.USD","LU0029864427.USD","LU0965509283.SGD","LU0128525929.USD","LU0426417589.USD","LU0943347566.SGD","LU1093756325.SGD","IE0002270589.USD","IE00BDGV0183.EUR","IE0000B7K699.USD","LU0234570918.USD","LU2112291526.USD","BK4588","LU0820561909.HKD","LU0109394709.USD","LU2237443465.HKD","BK4532","BK4533","LU1732799900.SGD","LU1074936037.SGD","LU2347655156.SGD","LU2471134796.USD","LU2756315318.SGD","LU0203345920.USD","LU0882574055.USD","LU0889565916.HKD","LU1066053197.SGD","LU1551013342.USD","LU0225771236.USD","LU0820562030.AUD","LU2023250330.USD","LU0942090050.USD","SG9999013999.USD","BIIB","LU0210528500.USD","LU1506573853.SGD","LU0683600562.USD","LU1929549753.HKD","SG9999002232.USD","LU0965508806.USD","SG9999015952.SGD","LU0069063385.USD","IE0002141913.USD","LU0511384066.AUD","IE00BVYPNW00.USD","BK4559","LU1023059063.AUD","IE00B42XCP33.USD","LU1057294990.SGD","LU1066051811.HKD","LU1196500208.SGD","LU0124676726.USD","LU0795875086.SGD","SG9999015978.USD","LU2487616109.SGD","LU1934455194.USD","LU0689626769.HKD","LU1718418525.SGD","LU2505996509.AUD","LU0203347892.USD","LU0689472784.USD","BK4550","IE00B4R5TH58.HKD","LU1551013425.SGD","LU0661504455.SGD","LU1983299246.USD","IE000F7OJYX1.SGD","LU1430594728.SGD","LU0070217475.USD","LU1934455277.USD","LU0432979614.USD","SG9999002224.SGD","IE00B7SZLL34.SGD","LU0320765646.SGD","LU0792757196.USD","LU1291159041.SGD","SG9999015986.USD","LU1267930813.SGD","SG9999003800.SGD","IE00BSNM7G36.USD","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632640929","title":"Press Release: FLUENT Enters into Definitive Agreement to sell Texas Business","url":"https://stock-news.laohu8.com/highlight/detail?id=2632640929","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632640929?lang=en_us&edition=fundamental","pubTime":"2026-05-02 04:52","pubTimestamp":1777668720,"startTime":"0","endTime":"0","summary":"TAMPA, Fla., May 01, 2026  -- FLUENT Corp.   , a vertically-integrated, multi-state cannabis company, today announced that it has entered into a definitive agreement  with Legacy Therapeutics, LLC , pursuant to which Legacy will acquire 100% of the issued and outstanding equity interests in Cansortium Texas, LLC , a subsidiary of the Company . The Transaction contemplates the sale of the Company's Texas business operations, which includes Cansortium Texas's license, cultivation, manufacturing, and delivery business in Schulenburg, Texas, as well as its Houston retail operations.Pursuant to the terms of the Purchase Agreement, which was signed May 1, 2026, the purchase price payable by Legacy is equal to $30 Million, of which $25M will be payable at closing and an amount equal to $2.5M will be payable on each of the first and second anniversary of the closing date. The Transaction is subject to applicable regulatory approvals and the satisfaction of certain other customary closing condi","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CNTMF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632640634","title":"Evolus Inc  expected to post a loss of 13 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2632640634","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632640634?lang=en_us&edition=fundamental","pubTime":"2026-05-02 04:46","pubTimestamp":1777668366,"startTime":"0","endTime":"0","summary":"Evolus Inc  expected to post a loss of13cents a share - Earnings Preview Evolus Inc EOLS.OQ EOLS.O is expected to  show a rise in quarterly revenue when it reports  results on May 4 for the period end","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260501:nL8N41E1YQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EOLS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632640246","title":"Context Therapeutics settles governance lawsuit with mootness fee","url":"https://stock-news.laohu8.com/highlight/detail?id=2632640246","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632640246?lang=en_us&edition=fundamental","pubTime":"2026-05-02 04:44","pubTimestamp":1777668268,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Context Therapeutics ( ($CNTX) ). On March 11, 2026, the Delaware Court of Chancery approved a consent judgment...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/context-therapeutics-settles-governance-lawsuit-with-mootness-fee?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/context-therapeutics-settles-governance-lawsuit-with-mootness-fee?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4007","CNTX","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632384640","title":"Nektar Therapeutics grants inducement equity awards to new hires under 2025 plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2632384640","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632384640?lang=en_us&edition=fundamental","pubTime":"2026-05-02 04:40","pubTimestamp":1777668034,"startTime":"0","endTime":"0","summary":"Nektar Therapeutics granted inducement equity awards on April 20, 2026 to six newly hired employees under its 2025 Inducement Plan.Awards comprised non-qualified stock options covering 28,450 shares plus 2,950 restricted stock units.Options carry an exercise price of $100.35 per share.Equity awards vest over four years, subject to continued employment.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260501:nNDL4Grdky:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","NKTR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632264038","title":"Processa R&D President David Young acquires 1,706 shares for $4,589.14","url":"https://stock-news.laohu8.com/highlight/detail?id=2632264038","media":"Reuters","labels":["shareholding","insiderTrades","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632264038?lang=en_us&edition=fundamental","pubTime":"2026-05-02 04:40","pubTimestamp":1777668030,"startTime":"0","endTime":"0","summary":"Processa Pharmaceuticals director David Young, President of Research & Development, reported purchase of 1,706 common shares at USD 2.69.Indirect holdings totaled 2,416 common shares, held via trust, family entities, CorLyst.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Processa Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 01, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260501:nNDL6XB9Gk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,insiderTrades,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PCSA"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"compareEarnings":[{"period":"1week","weight":0.0094},{"period":"1month","weight":0.0998},{"period":"3month","weight":0.0414},{"period":"6month","weight":0.0566},{"period":"1year","weight":0.2904},{"period":"ytd","weight":0.0568}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"name":"BK4007","nameEN":"BK4007"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Pharmacy(BK4007),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Pharmacy(BK4007) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Pharmacy,BK4007,Pharmacy股票,Pharmacy股票老虎,Pharmacy股票老虎国际,Pharmacy行情,Pharmacy股票行情,Pharmacy股价,Pharmacy股市,Pharmacy股票价格,Pharmacy股票交易,Pharmacy股票购买,Pharmacy股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Pharmacy(BK4007),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Pharmacy(BK4007) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction